Skip to content
10-Q

Quarterly Report

PACIRA BIOSCIENCES, INC. PCRX

0001628280-25-050176

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 5, 2025 43.02M sh
Shares Diluted Q3 2025 · Sep 30, 2025 44.46M sh
Shares Diluted Q3 2025 · Sep 30, 2025 45.73M sh
Shares Diluted Q3 2025 · Sep 30, 2024 46.13M sh
Shares Diluted Q3 2025 · Sep 30, 2024 46.27M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $100.08M
Stock Repurchased Q3 2025 · Sep 30, 2024 $25M
Capex Q3 2025 · Sep 30, 2025 $15.12M
Capex Q3 2025 · Sep 30, 2024 $8.52M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $108.31M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $156.26M
Long Term Debt Q3 2025 · Sep 30, 2025 $376.72M
Long Term Debt Q3 2025 · Dec 31, 2024 $383.55M
Short Term Debt Q3 2025 · Sep 30, 2025 $0
Short Term Debt Q3 2025 · Dec 31, 2024 $201.78M
Short Term Investments Q3 2025 · Sep 30, 2025 $98.75M
Short Term Investments Q3 2025 · Dec 31, 2024 $207.84M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $147.59M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $276.77M
Stockholders Equity Q3 2025 · Sep 30, 2025 $727.21M
Stockholders Equity Q3 2025 · Jun 30, 2025 $757.77M
Stockholders Equity Q3 2025 · Dec 31, 2024 $778.35M
Stockholders Equity Q3 2025 · Sep 30, 2024 $749.58M
Stockholders Equity Q3 2025 · Jun 30, 2024 $879.28M
Stockholders Equity Q3 2025 · Dec 31, 2023 $870.13M
Current Liabilities Q3 2025 · Sep 30, 2025 $107.08M
Current Liabilities Q3 2025 · Dec 31, 2024 $309.92M
Total Liabilities Q3 2025 · Sep 30, 2025 $570.36M
Total Liabilities Q3 2025 · Dec 31, 2024 $775.17M
Current Assets Q3 2025 · Sep 30, 2025 $562.75M
Current Assets Q3 2025 · Dec 31, 2024 $745.13M
Total Assets Q3 2025 · Sep 30, 2025 $1.3B
Total Assets Q3 2025 · Dec 31, 2024 $1.55B
Eps Diluted Q3 2025 · Sep 30, 2025 $0.12
Eps Diluted Q3 2025 · Sep 30, 2025 $0.12
Eps Diluted Q3 2025 · Sep 30, 2024 −$3.11
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.50
Eps Basic Q3 2025 · Sep 30, 2025 $0.12
Eps Basic Q3 2025 · Sep 30, 2025 $0.12
Eps Basic Q3 2025 · Sep 30, 2024 −$3.11
Eps Basic Q3 2025 · Sep 30, 2024 −$2.50
Sga Expense Q3 2025 · Sep 30, 2025 $91.8M
Sga Expense Q3 2025 · Sep 30, 2025 $267.15M
Sga Expense Q3 2025 · Sep 30, 2024 $74.33M
Sga Expense Q3 2025 · Sep 30, 2024 $214.49M
Rd Expense Q3 2025 · Sep 30, 2025 $25.97M
Rd Expense Q3 2025 · Sep 30, 2025 $79.86M
Rd Expense Q3 2025 · Sep 30, 2024 $19.1M
Rd Expense Q3 2025 · Sep 30, 2024 $57.68M
Net Income Q3 2025 · Sep 30, 2025 $5.43M
Net Income Q3 2025 · Sep 30, 2025 $5.4M
Net Income Q3 2025 · Sep 30, 2024 −$143.47M
Net Income Q3 2025 · Sep 30, 2024 −$115.6M
Operating Income Q3 2025 · Sep 30, 2025 $6.36M
Operating Income Q3 2025 · Sep 30, 2025 $16.85M
Operating Income Q3 2025 · Sep 30, 2024 −$139.53M
Operating Income Q3 2025 · Sep 30, 2024 −$98.08M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $34.28M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $109.45M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $38.86M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $130.54M
Revenue Q3 2025 · Sep 30, 2025 $179.52M
Revenue Q3 2025 · Sep 30, 2025 $529.54M
Revenue Q3 2025 · Sep 30, 2024 $168.57M
Revenue Q3 2025 · Sep 30, 2024 $513.71M